Abstract
Hematopoietic stem cells represent the most studied and understood adult stem cell, and have consequently set the trends for the investigation of a wide array of stem cells, while their clinical use for over half a century and ever improving efficacy encourages the view that stem cell therapy will one day be useful in the treatment of a whole host of diseases that involve cellular loss. In this chapter we describe how hematopoietic stem cells can be identified, isolated and characterized, and how important it is to be able to conduct experiments on animal models as well as humans, especially as studies in animals can provide the best, sometimes only, way to test stem cell potential and new protocols for their therapeutic use. The increasing possibilities for bone marrow regenerative medicine raised by the rapid developments in our ability to derive pluripotent stem cells from any individual are discussed, in particular because these are likely to be a very effective source of hematopoietic stem cells for all people requiring them to be replaced, as well as the exciting prospect that they can provide a route for the correction of inherited diseases affecting the blood system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams GB, Scadden DT (2008) A niche opportunity for stem cell therapeutics. Gene Ther 15:96–99
Adolfsson J, Borge OJ, Bryder D et al (2001) Upregulation of Flt3 expression within the bone marrow Lin(−)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659–669
Adolfsson J, Månsson R, Buza-Vidas N et al (2005) Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121:295–306
Akashi K, Traver D, Miyamoto T et al (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193–197
Almeida-Porada G, Porada C, Gupta N et al (2007) The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts’ potential. Exp Hematol 35:1594–1600
Ando K (2002) Human CD34- hematopoietic stem cells: basic features and clinical relevance. Int J Hematol 75:370–375
in ‘t Anker PS, Noort WA, Kruisselbrink AB et al (2003) Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31:881–889
Antonchuk J, Sauvageau G, Humphries RK (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39–45
Arai F, Hirao A, Ohmura M et al (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118:149–161
Balazs AB, Fabian AJ, Esmon CT et al (2006) Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 107:2317–2321
Baum CM, Weissman IL, Tsukamoto AS et al (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804–2808
Bensidhoum M, Chapel A, Francois S et al (2004) Homing of in vitro expanded Stro-1− or Stro-1+ mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103:3313–3319
Bhatia M (2007) Hematopoietic development from human embryonic stem cells. Hematol Am Soc Hematol Educ Progr 2007:11–16
Bhatia M, Wang JC, Kapp U et al (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320–5325
Bhatia M, Bonnet D, Murdoch B et al (1998) A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4:1038–1045
Bonnet D, Bhatia M, Wang JC et al (1999) Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant 23:203–209
Bradley TR, Metcalf D (1966) The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 44:287–299
Challen GA, Boles NC, Lin KK et al (2009) Mouse hematopoietic stem cell identification and analysis. Cytometry A 75:14–24
Challen GA, Boles NC, Chambers SM et al (2010) Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6:265–278
Chambers SM, Goodell MA (2007) Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 3:201–211
Chen BP, Galy A, Kyoizumi S et al (1994) Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 84:2497–2505
Chen CZ, Li L, Li M et al (2003) The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells. Immunity 19:525–533
Cho RH, Sieburg HB, Muller-Sieburg CE (2008) A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111:5553–5561
Christensen JL, Weissman IL (2001) Flk-2 is a marker in hematopoietic stem cell differentiation: a simple model to isolate long-term stem cells. Proc Natl Acad Sci USA 98:14541–14546
Chute JP (2006) Stem cell homing. Curr Opin Hematol 13:399–406
Coffer PJ, Burgering BM (2007) Stressed marrow: FoxOs stem tumour growth. Nat Cell Biol 9:251–253
Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813–1826
Craig W, Kay R, Cutler RL et al (1993) Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 177:1331–1342
Cumano A, Godin I (2007) Ontogeny of the hematopoietic system. Annu Rev Immunol 25:745–785
de Haan G, Weersing E, Dontje B et al (2003) In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell 4:241–251
Dexter TM, Allen TD, Lajtha LG (1977) Conditions controlling the proliferation of hematopoietic stem cells in vitro. J Cell Physiol 91:335–344
Dick JE, Magli MC, Huszar D et al (1985) Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell 42:71–79
Doulatov S, Notta F, Laurenti E et al (2012) Hematopoiesis: a human perspective. Cell Stem Cell 10:120–136
Dykstra B, de Haan G (2008) Hematopoietic stem cell aging and self-renewal. Cell Tissue Res 331:91–101
Dzierzak E, Speck NA (2008) Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol 9:129–136
Dzierzak E, Medvinsky A, de Bruijn M (1998) Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol Today 19:228–236
Ema H, Takano H, Sudo K et al (2000) In vitro self-renewal division of hematopoietic stem cells. J Exp Med 192:1281–1288
Engelhardt M, Lübbert M, Guo Y (2002) CD34(+) or CD34(−): which is the more primitive? Leukemia 16:1603–1608
Fraser CC, Chen BP, Webb S et al (1995) Circulation of human hematopoietic cells in severe combined immunodeficient mice after Cl2MDP-liposome-mediated macrophage depletion. Blood 86:183–192
Fukuda S, Bian H, King AG et al (2007) The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 110:860–869
Gallacher L, Murdoch B, Wu DM et al (2000) Isolation and characterization of human CD34(−)Lin(−) and CD34(+)Lin(−) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95:2813–2820
Goardon N, Marchi E, Atzberger A et al (2011) Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19:138–152
Goldman JP, Blundell MP, Lopes L et al (1998) Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 103:335–342
Goldstone SD, Milligan AD, Hunt NH (1996) Oxidative signalling and gene expression during lymphocyte activation. Biochim Biophys Acta 1314:175–182
Goodell MA, Brose K, Paradis G et al (1996) Isolation and functional properties of murine hemopoietic stem cells that are replicating in vivo. J Exp Med 183:1797–1806
Goodell MA, Rosenzweig M, Kim H et al (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3:1337–1345
Greiner DL, Hesselton RA, Shultz LD (1998) SCID mouse models of human stem cell engraftment. Stem Cells 16:166–177
Guo Y, Lübbert M, Engelhardt M (2003) CD34- hematopoietic stem cells: current concepts and controversies. Stem Cells 21:15–20
Hanna J, Wernig M, Markoulaki S et al (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920–1923
Hao QL, Shah AJ, Thiemann FT et al (1995) A functional comparison of CD34+ CD38− cells in cord blood and bone marrow. Blood 86:3745–3753
Harrison DE, Jordan CT, Zhong RK et al (1993) Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple bionomial, correlation and covariance calculations. Exp Hematol 21:206–219
Hess DA, Wirthlin L, Craft TP et al (2006) Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107:2162–2169
Hochedlinger K, Plath K (2009) Epigenetic reprogramming and induced pluripotency. Development 136:509–523
Hoebeke I, De Smedt M, Stolz F et al (2007) T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(−)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes. Leukemia 21:311–319
Ishii M, Matsuoka Y, Sasaki Y et al (2011) Development of a high-resolution purification method for precise functional characterization of primitive human cord blood-derived CD34-negative SCID-repopulating cells. Exp Hematol 39:203–213
Ishikawa F, Yasukawa M, Lyons B et al (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 106:1565–1573
Ito M, Hiramatsu H, Kobayashi K et al (2002) NOD/SCIDgamma(c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175–3182
Ito M, Kobayashi K, Nakahata T (2008) NOD/Shi-scid IL2rgamma(null) (NOG) mice are more appropriate for humanized mouse models. Curr Top Microbiol Immunol 324:53–76
Jang YY, Sharkis SJ (2007) A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110:3056–3063
Janzen V, Forkert R, Fleming HE et al (2006) Stem cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443:42142–42146
Kamel-Reid S, Dick JE (1988) Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706–1709
Kastan MB, Schlaffer E, Russo JE et al (1990) Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 75:1947–1950
Katayama Y, Battista M, Kao WM et al (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124:407–421
Kaufman DS, Hanson ET, Lewis RL et al (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 98:10716–10721
Kent DG, Copley MR, Benz C et al (2009) Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential. Blood 113:6342–63450
Kiel MJ, Morrison SJ (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8:290–301
Kiel MJ, Yilmaz OH, Iwashita T et al (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109–1121
Kimura T, Asada R, Wang J et al (2007) Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells 25:1348–1355
Kollet O, Peled A, Byk TB et al (2000) Beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95:3102–3105
Kondo M, Weissman IL, Akashi K (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661–672
Kusadasi N, van Soest PL, Mayen AE et al (2000) Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia 14:1944–1953
Kushida T, Inaba M, Hisha H et al (2001) Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97:3292–3299
Kyba M, Perlingeiro RC, Daley GQ (2002) HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109:29–37
Lai AY, Kondo M (2006) Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med 203:1867–1873
Lapidot T, Pflumio F, Doedens M et al (1992) Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137–1141
Lapidot T, Dar A, Kollet O (2005) How do stem cells find their way home? Blood 106:1901–1910
Larochelle A, Savora M, Wiggins M et al (2011) Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers. Blood 117:1550–1554
Ledran MH, Krassowska A, Armstrong L et al (2008) Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3:85–98
Lemieux ME, Rebel VI, Lansdorp PM et al (1995) Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow “switch” cultures. Blood 86:1339–1347
Lemischka IR, Raulet DH, Mulligan RC (1986) Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45:917–927
Li Z, Li L (2006) Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci 31:589–595
Lo Celso C, Fleming HE, Wu JW et al (2009) Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457:92–96
Majeti R, Park CY, Weissman IL (2007) Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1:635–645
Mayani H, Dragowska W, Lansdorp PM (1993) Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood 81:3252–3258
Mazurier F, Fontanellas A, Salesse S et al (1999) A novel immunodeficient mouse model RAG2 x common cytokine receptor gamma chain double mutants requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res 19:533–541
McCune JM, Namikawa R, Kaneshima H et al (1988) The SCID-hu mouse: murine model for the analysis of human hematoplymphoid differentiation and function. Science 241:1632–1639
McKenzie JL, Gan OI, Doedens M et al (2005) Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 106:1259–1261
McKenzie JL, Gan OI, Doedens M et al (2006) Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat Immunol 7:1225–1233
McKenzie JL, Takenaka K, Gan OI et al (2007) Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin-CD34+ CD38− population. Blood 109:543–545
Mercier FE, Ragu C, Scadden DT (2011) The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 12:49–60
Mikkola HK, Orkin SH (2006) The journey of developing hematopoietic stem cells. Development 133:3733–3744
Moore MA, Williams N, Metcalf D (1973) In vitro colony formation by normal and leukemic human hematopoitic cells: characterization of the colony-forming cells. J Natl Cancer Inst 50:603–623
Moreno-Gimeno I, Ledran MH, Lako M (2010) Hematopoietic differentiation from human ESCs as a model for developmental studies and future clinical translations. Invited review following the FEBS anniversary prize received on 5 July 2009 at the 34th FEBS congress in Prague. FEBS J 277:5014–5025
Namikawa R, Weilbaecher KN, Kaneshima H et al (1990) Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 172:1055–1063
Narayan AD, Chase JL, Lewis RL et al (2006) Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 107:2180–2183
Niwa A, Umeda K, Chang H et al (2009) Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemangiogenic progenitors. J Cell Physiol 221:367–377
Nolta JA, Hanley MB, Kohn DB (1994) Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 83:3041–3051
Noort WA, Kruisselbrink AB, in ‘t Anker PS et al (2002) Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 30:870–878
Notta F, Doulatov S, Laurenti E et al (2011) Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333:218–221
Okada S, Nakauchi H, Nagayoshi K et al (1992) In vivo and in vitro stem cell function of c-kit and Sca-1-positive murine hematopoietic cells. Blood 80:3044–3050
Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313–317
Olsen AL, Stachura DL, Weiss MJ (2006) Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood 107:1265–1275
Osawa M, Hanada K, Hamada H et al (1996) Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242–245
Pang WW, Price EA, Sahoo D et al (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 108:20012–20017
Pearson T, Greiner DL, Shultz LD (2008) Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol 324:25–51
Pelus LM, Fukuda S (2008) Chemokine mobilized adult stem cells: defining a better hematopoietic graft. Leukemia 22:466–473
Ploemacher RE, van der Sluijs JP, Voerman JS et al (1989) An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74:2755–2763
Ploemacher RE, van der Sluijs JP, van Beurden CA et al (1991) Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulation and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78:2527–2533
Pronk CJ, Rossi DJ, Mansson R et al (2007) Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor hierarchy. Cell Stem Cell 1:428–442
Purton LE, Scadden DT (2007) Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell 1:263–270
Raaijmakers MH, Scadden DT (2008) Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol 15:301–306
Raya A, Rodríguez-Pizà I, Guenechea G et al (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460:53–59
Risueño RM, Sachlos E, Lee JH et al (2012) Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate micro RNAs in vivo reveals a block in xenograft hematopoietic regeneration. Stem Cells 30:131–139
Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481:295–305
Rongvaux A, Willinger T, Takizawa H et al (2011) Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci USA 108:2378–2383
Sardina JL, López-Ruano G, Sánchez-Sánchez B et al (2012) Reactive oxygen species: are they important for hematopoiesis? Crit Rev Oncol Hematol 81:257–274
Schenke-Layland K, Rhodes KE, Angelis E et al (2008) Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26:1537–1546
Schmitt TM, Zúñiga-Pflücker JC (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749–756
Shultz LD, Schweitzer PA, Christianson SW et al (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180–191
Sintes J, Romero X, Marin P et al (2008) Differential expression of CD150 (SLAM) family receptors by human hematopoietic stem and progenitor cells. Exp Hematol 36:1199–1204
Sitnicka E, Buza-Vidas N, Larsson S et al (2003) Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102:881–886
Six EM, Bonhomme D, Monteiro M et al (2007) A human postnatal lymphoid progenitor capable of circulating and seeding the thymus. J Exp Med 204:3085–3093
Spangrude GJ, Johnson GR (1990) Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA 87:7433–7437
Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241:58–62
Spiegel A, Kalinkovich A, Shivtiel S et al (2008) Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell 3:484–492
Srour EF, Zanjani ED, Cornetta K et al (1993) Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 82:3333–3342
Storms RW, Trujillo AP, Springer JB et al (1999) Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 96:9118–9123
Sutherland HJ, Eaves CJ, Eaves AC et al (1989) Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563–1570
Suzuki T, Yokoyama Y, Kumano K et al (2006) Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein. Stem Cells 24:245624–245665
Swierczek SI, Agarwal N, Nussenzveig RH et al (2008) Hematopoiesis is not clonal in healthy elderly women. Blood 112:3186–3193
Szabo E, Rampalli S, Risueño RM et al (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468:521–526
Szilvassy SJ, Humphries RK, Lansdorp PM et al (1990) Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci USA 87:8736–8740
Taichman RS (2005) Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105:2631–2639
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Takano H, Ema H, Sudo K et al (2004) Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med 199:295–302
Tatla S, Woodhead F et al (1999) The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. Free Radic Biol Med 26:14–24
Thomas ED, Lochte HL Jr, Lu WC et al (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257:491–496
Tian X, Kaufman DS (2008) Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls. Curr Opin Hematol 15:312–318
Till JE, McCulloch EA (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213–222
Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344
Ueda T, Tsuji K, Yoshino H et al (2000) Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 105:1013–1021
Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84
van Os R, Kamminga LM, de Haan G (2004) Stem cell assays: something old, something new, something borrowed. Stem Cells 22:118111–118190
van Rijn RS, Simonetti ER, Hagenbeek A et al (2003) A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG-/- gammac-/- double-mutant mice. Blood 102:2522–2531
Vodyanik MA, Bork JA, Thomson JA et al (2005) Human embryonic stem cell-derived CD34+ cells: efficient production in coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105:617–626
Wang JC, Doedens M, Dick JE (1997) Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating assay. Blood 89:3919–3924
Wang J, Kimura T, Asada R et al (2003) SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 101:2924–2931
Whitlock CA, Witte ON (1982) Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79:3608–3612
Willinger T, Rongvaux A, Stowig T et al (2011) Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol 32:321–327
Wilmut I, Schnieke AF, McWhir J et al (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385:810–813
Wilson A, Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6:93–106
Woolthuis CM, de Haan G, Huls G (2011) Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects? Curr Opin Immunol 23:512–517
Yahata T, Ando K, Sato T et al (2003) A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101:2905–2913
Yang L, Bryder D, Adolfsson J et al (2005) Identification of Lin(−)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105:2717–2723
Yeoh JS, van Os R, Weersing E et al (2006) Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem Cells 24:1564–1572
Yin AH, Miraglia S, Zanjani ED et al (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002–5012
Yu J, Hu K, Smugga-Otto K et al (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797–801
Zanjani ED, Pallavicini MG, Ascensao JL et al (1992) Engraftment and long-term expression of human fetal hematopoietic stem cells in sheep following transplantation in utero. J Clin Invest 89:1178–1188
Zanjani ED, Srour EF, Hoffman R (1995) Retention of long-term repopulating ability of xenogeneic transplanted purified adult human bone marrow hematopoietic stem cells in sheep. J Lab Clin Med 126:24–28
Zanjani ED, Almeida-Porada G, Livingston AG et al (1998) Human bone marrow CD34− cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 26:353–360
Zhang CC, Kaba M, Ge G et al (2006) Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 12:240–245
Zhang CC, Kaba M, Iizuka S et al (2008) Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111:3415–3423
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Clarke, M.L., Frampton, J. (2013). Hematopoietic Stem Cells. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5690-8_10
Download citation
DOI: https://doi.org/10.1007/978-94-007-5690-8_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5689-2
Online ISBN: 978-94-007-5690-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)